Drug Trial Radar · NCT04599972
An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)
Last checked: Nov 19, 2026Latest source record: Apr 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
304
Actual
Start
Oct 26, 2020
Primary completion
Jan 21, 2022
Study completion Jan 28, 2022
Sponsor
- Lead sponsor
- Orasis Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Oct 23, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 45 years, up to 64 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.
Conditions
- Presbyopia
Interventions
CSF-1Drug
One drop bilaterally twice daily for approximately 2 weeks.
VehicleDrug
One drop bilaterally twice daily for approximately 2 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With a ≥ 3-line Gain in BDCVA (Best Distance-Corrected Visual Acuity) at 40cm and no Loss in BDCVA ≥ 5 Letters at 4m on Day 8, 1 Hour Post-Dose 1.Time frame: Baseline (Day 1) to Day 8 (1 hour post-Dose 1)
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Orasis Investigative Site
Chandler, Arizona
Orasis Investigative Site
Mesa, Arizona
Orasis Investigative Site
Phoenix, Arizona
Orasis Investigative Site
Garden Grove, California
Orasis Investigative Site
Mission Hills, California
Orasis Investigative Site
Newport Beach, California
Orasis Investigative Site
Petaluma, California
Orasis Investigative Site
Littleton, Colorado
Orasis Investigative Site
Danbury, Connecticut
Orasis Investigative Site
Delray Beach, Florida
Orasis Investigative Site
Rock Island, Illinois
Orasis Investigative Site
Rochester, New York
Orasis Investigative Site
Kingston, Pennsylvania
Orasis Investigative Site
Cedar Park, Texas
Orasis Investigative Site
San Antonio, Texas
Orasis Investigative Site
Clinton, Utah
Orasis Investigative Site
Draper, Utah
Orasis Investigative Site
Lynchburg, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.